BioWarn

BioWarn is a biotechnology company specializing in the development of autonomous, real-time pathogen detection systems for biodefense and public health surveillance. The company's core technology, the Bio-Warn System, functions as an automated laboratory that continuously monitors environmental air and liquid samples for biological threats, including bacteria, viruses, and toxins. Following its acquisition by Innova Medical Group, the platform has been prominently adapted for the rapid detection of SARS-CoV-2 in high-traffic public environments and critical infrastructure. The system acts as a "biological smoke detector," providing immediate alerts to facilitate early intervention and prevent the spread of infectious diseases. BioWarn's solutions are engineered for high sensitivity and minimal maintenance, allowing for scalable deployment in both government and commercial sectors.